Decoding the non-coding RNAs in Alzheimer's disease

Cellular and Molecular Life Sciences

Volumn 69, Issue 21, 2012, Pages 3543-3559

  Schonrock, Nicole ^a,b   Götz, Jürgen ^c  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Alzheimer's disease (AD); Amyloid beta; MicroRNAs; Non coding RNAs

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; MESSENGER RNA; MICRORNA; MICRORNA 132; MICRORNA 15; MITOGEN ACTIVATED PROTEIN KINASE 3; TAU PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BRAIN DEVELOPMENT; BRAIN FUNCTION; COGNITIVE DEFECT; CYTOSKELETON; EPIGENETICS; EXON; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE REGULATORY NETWORK; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INNATE IMMUNITY; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REVIEW; RNA SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MICRORNAS; RNA, UNTRANSLATED; SYNAPSES; TAU PROTEINS;

EID: 84867888439     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1125-z     Document Type: Review

References (145)

1. Azevedo FA, Carvalho LR, Grinberg LT, Farfel JM, Ferretti RE, Leite RE, Jacob Filho W, Lent R, Herculano-Houzel S (2009) Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol 513(5):532-541. doi:10.1002/cne.21974
2. Ooi L, Wood IC (2008) Regulation of gene expression in the nervous system. Biochem J 414(3):327-341. doi:10.1042/BJ20080963
3. Mattick JS (2011) The central role of RNA in human development and cognition. FEBS Lett 585(11):1600-1616. doi: 10.1016/j.febslet.2011.05.001
4. Amaral PP, Dinger ME, Mercer TR, Mattick JS (2008) The eukaryotic genome as an RNA machine. Science 319(5871): 1787-1789. doi:10.1126/science.1155472
5. St Laurent G 3rd, Wahlestedt C (2007) Non-coding RNAs: couplers of analog and digital information in nervous system function? Trends Neurosci 30(12):612-621. doi:10.1016/j.tins. 2007.10.002
6. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer's disease. Lancet 377(9770):1019-1031. doi:10.1016/S0140-6736(10) 61349-9
7. Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ (2008) ALS and FTLD: two faces of TDP-43 proteinopathy. Eur J Neurol 15(8):772-780. doi:10.1111/j.1468-1331.2008.02195.x
8. Gotz J (2001) Tau and transgenic animal models. Brain Res Brain Res Rev 35(3):266-286
9. Schonrock N, Matamales M, Ittner LM, Gotz J (2012) MicroRNA networks surrounding APP and amyloid-beta metabolism - Implications for Alzheimer's disease. Exp Neurol 235(2):447- 454. doi:10.1016/j.expneurol.2011.11.013
10. Brandt R, Leschik J (2004) Functional interactions of tau and their relevance for Alzheimer's disease. Curr Alzheimer Res 1(4):255-269
11. Hanger DP, Noble W (2011) Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation. Int J Alzheimers Dis 2011:352805. doi:10.4061/2011/352805
12. Chen F, David D, Ferrari A, Gotz J (2004) Posttranslational modifications of tau - role in human tauopathies and modeling in transgenic animals. Curr Drug Targets 5(6):503-515
13. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Gotz J (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142(3):387-397. doi:10.1016/j.cell.2010. 06.036
14. Alonso AC, Grundke-Iqbal I, Iqbal K (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2(7): 783-787
15. Bertram L, Tanzi RE (2008) Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9(10):768-778. doi:10.1038/nrn2494
16. David DC, Ittner LM, Gehrig P, Nergenau D, Shepherd C, Halliday G, Gotz J (2006) Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes. Proteomics 6(24):6566-6577. doi:10.1002/pmic.200600634
17. Gotz J, Ittner LM (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9(7):532-544. doi:10.1038/nrn2420
18. Pauli A, Rinn JL, Schier AF (2011) Non-coding RNAs as regulators of embryogenesis. Nat Rev Genet 12(2):136-149. doi: 10.1038/nrg2904
19. Mattick JS, Amaral PP, Dinger ME, Mercer TR, Mehler MF (2009) RNA regulation of epigenetic processes. Bioessays 31(1):51-59. doi:10.1002/bies. 080099
20. Suh N, Blelloch R (2011) Small RNAs in early mammalian development: from gametes to gastrulation. Development 138(9):1653-1661. doi:10.1242/dev.056234
21. Lee RC, Feinbaum RL, Ambros V (1993) The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843-854
22. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23(20):4051-4060. doi:10.1038/sj.emboj.7600385
23. Cai X, Hagedorn CH, Cullen BR (2004) Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10(12):1957-1966. doi:10.1261/rna. 7135204
24. Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351-379. doi:10.1146/annurev-biochem-060308- 103103
25. Eulalio A, Huntzinger E, Izaurralde E (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132(1):9-14. doi: 10.1016/j.cell.2007.12.024
26. Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318(5858):1931-1934. doi:10.1126/science. 1149460
27. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105(5): 1608-1613. doi:10.1073/pnas.0707594105
28. Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19(1):92-105. doi:10.1101/gr.082701. 108
29. Amaral PP, Clark MB, Gascoigne DK, Dinger ME, Mattick JS (2011) lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res 39:146-151. doi:10.1093/nar/ gkq1138
30. Wilusz JE, Sunwoo H, Spector DL (2009) Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23(13):1494-1504. doi:10.1101/gad. 1800909
31. Magistri M, Faghihi MA, St Laurent G 3rd, Wahlestedt C (2012) Regulation of chromatin structure by long non-coding RNAs: focus on natural antisense transcripts. Trends Genet. doi:10.1016/ j.tig.2012.03.013
32. Cao X, Yeo G, Muotri AR, Kuwabara T, Gage FH (2006) Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci 29:77-103. doi:10.1146/annurev.neuro.29.051 605.112839
33. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS (2008) Specific expression of long non-coding RNAs in the mouse brain. Proc Natl Acad Sci USA 105(2):716-721. doi: 10.1073/pnas.0706729105
34. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foa R, Schliwka J, Fuchs U, Novosel A, Muller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, Palkovits M, Di Lauro R, Wernet P, Macino G, Rogler CE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, Tam W, Brownstein MJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129(7):1401-1414. doi: 10.1016/j.cell.2007.04.040
35. Kosik KS, Krichevsky AM (2005) The elegance of the microRNAs: a neuronal perspective. Neuron 47(6):779-782. doi: 10.1016/j.neuron.2005.08.019
36. Mehler MF, Mattick JS (2006) Non-coding RNAs in the nervous system. J Physiol 575(Pt 2):333-341. doi:10.1113/jphysiol. 2006.113191
37. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL (2008) The bifunctional microRNA miR-9/miR-9 regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 28(53):14341-14346. doi:10.1523/JNEUROSCI. 2390-08. 2008
38. Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ (2008) A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis 29(3):438-445. doi:10.1016/j.nbd.2007.11.001
39. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science 317(5842):1220-1224. doi:10.1126/science.1140481
40. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8(2):R27. doi:10.1186/gb-2007-8-2-r27
41. Kuhn DE, Nuovo GJ, Martin MM, Malana GE, Pleister AP, Jiang J, Schmittgen TD, Terry AV Jr, Gardiner K, Head E, Feldman DS, Elton TS (2008) Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochem Biophys Res Commun 370(3):473-477. doi:10.1016/ j.bbrc.2008.03.120
42. Lin Q, Wei W, Coelho CM, Li X, Baker-Andresen D, Dudley K, Ratnu VS, Boskovic Z, Kobor MS, Sun YE, Bredy TW (2011) The brain-specific microRNA miR-128b regulates the formation of fear-extinction memory. Nat Neurosci 14(9):1115-1117. doi: 10.1038/nn.2891
43. Ling SC, Albuquerque CP, Han JS, Lagier-Tourenne C, Tokunaga S, Zhou H, Cleveland DW (2010) ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci USA 107(30):13318-13323. doi:10.1073/pnas.1008227107
44. Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, Batterton MN, Tada T, Dolan BM, Sharp PA, Sheng M (2010) Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65(3): 373-384. doi:10.1016/j.neuron.2010.01.005
45. Stark KL, Xu B, Bagchi A, Lai WS, Liu H, Hsu R, Wan X, Pavlidis P, Mills AA, Karayiorgou M, Gogos JA (2008) Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet 40(6):751-760. doi: 10.1038/ng.138
46. Tal TL, Tanguay RL (2012) Non-coding RNAs-Novel targets in neurotoxicity. Neurotoxicology. doi:10.1016/j.neuro.2012.02.013
47. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, Cabili MN, Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N, Bernstein BE, Kellis M, Regev A, Rinn JL, Lander ES (2009) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458(7235):223-227. doi:10.1038/ nature07672
48. Mercer TR, Qureshi IA, Gokhan S, Dinger ME, Li G, Mattick JS, Mehler MF (2010) Long non-coding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. BMC Neurosci 11:14. doi:10.1186/1471-2202- 11-14
49. Gordon FE, Nutt CL, Cheunsuchon P, Nakayama Y, Provencher KA, Rice KA, Zhou Y, Zhang X, Klibanski A (2010) Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology 151(6):2443-2452. doi:10.1210/en. 2009-1151
50. Bond AM, Vangompel MJ, Sametsky EA, Clark MF, Savage JC, Disterhoft JF, Kohtz JD (2009) Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat Neurosci 12(8):1020-1027. doi:10.1038/nn.2371
51. Lewejohann L, Skryabin BV, Sachser N, Prehn C, Heiduschka P, Thanos S, Jordan U, Dell'Omo G, Vyssotski AL, Pleskacheva MG, Lipp HP, Tiedge H, Brosius J, Prior H (2004) Role of a neuronal small non-messenger RNA: behavioural alterations in BC1 RNA-deleted mice. Behav Brain Res 154(1):273-289. doi: 10.1016/j.bbr.2004.02.015
52. Salta E, De Strooper B (2012) Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol 11(2): 189-200. doi:10.1016/S1474- 4422(11)70286-1
53. Hoerndli F, David DC, Gotz J (2005) Functional genomics meets neurodegenerative disorders. Part II: application and data integration. Prog Neurobiol 76(3):169-188. doi:10.1016/j. pneurobio.2005.07.002
54. Benetti F, Gustincich S, Legname G (2012) Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits. Expert Opin Drug Discov 7(3):245-259. doi:10.1517/17460 441.2012.659661
55. Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, Boscolo FS, Carson CT, Laurent LC, Marsala M, Gage FH, Remes AM, Koo EH, Goldstein LS (2012) Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 482(7384): 216-220. doi:10.1038/nature10821
56. Courtney E, Kornfeld S, Janitz K, Janitz M (2010) Transcriptome profiling in neurodegenerative disease. J Neurosci Methods 193(2):189-202. doi:10.1016/j.jneumeth.2010.08. 018
57. Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. NeuroReport 18(3):297-300. doi:10.1097/WNR.0b013e3280148e8b
58. Lukiw WJ, Zhao Y, Cui JG (2008) An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283(46): 31315-31322. doi:10.1074/jbc.M805371200
59. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT (2008) The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28(5): 1213-1223. doi:10.1523/JNEUROSCI.5065-07.2008
60. Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De Strooper B (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/ beta-secretase expression. Proc Natl Acad Sci USA 105(17): 6415-6420. doi:10.1073/pnas.0710263105
61. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, Roses AD, Richards CA (2008) Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14(1):27-41
62. Schipper HM, Maes OC, Chertkow HM, Wang E (2007) microRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Bio 1:263-274
63. Hebert SS, Horre K, Nicolai L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B (2009) microRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 33(3):422-428. doi:10.1016/j.nbd.2008.11.009
64. Sethi P, Lukiw WJ (2009) micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 459(2):100-104. doi: 10.1016/j.neulet.2009.04.052
65. Nunez-Iglesias J, Liu CC, Morgan TE, Finch CE, Zhou XJ (2010) Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS ONE 5(2):e8898. doi:10.1371/journal. pone. 0008898
66. Shioya M, Obayashi S, Tabunoki H, Arima K, Saito Y, Ishida T, Satoh J (2010) Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol 36(4):320-330. doi:10.1111/j.1365-2990.2010.01 076.x
67. Hebert SS, De Strooper B (2009) Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci 32(4):199-206. doi:10.1016/j.tins. 2008.12.003
68. Delay C, Hebert SS (2011) microRNAs and Alzheimer's disease mouse models: current insights and future research avenues. Int J Alzheimers Dis 2011:894938. doi:10.4061/2011/894938
69. Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X, Huang L, Liu Y, Zhang L, Qin C (2009) miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull 80(4-5):268-273. doi:10.1016/ j.brainresbull.2009.08.006
70. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102(39):13944-13949. doi:10.1073/ pnas.0506654102
71. Gotz J, Eckert A, Matamales M, Ittner LM, Liu X (2011) Modes of Abeta toxicity in Alzheimer's disease. Cell Mol Life Sci 68(20):3359-3375. doi:10.1007/s00018-011-0750-2
72. Schonrock N, Ke YD, Humphreys D, Staufenbiel M, Ittner LM, Preiss T, Gotz J (2010) Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS ONE 5(6):e11070. doi:10.1371/journal.pone.0011070
73. Delay C, Mandemakers W, Hebert SS (2012) microRNAs in Alzheimer's disease. Neurobiol Dis 46(2):285-290. doi: 10.1016/j.nbd.2012.01.003
74. Donev R, Newall A, Thome J, Sheer D (2007) A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms. Mol Psychiatry 12(7):681-690. doi:10.1038/sj.mp. 4001971
75. Smith P, Al Hashimi A, Girard J, Delay C, Hebert SS (2011) In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J Neurochem 116(2):240-247. doi:10.1111/ j.1471-4159.2010.07097.x
76. Papagiannakopoulos T, Kosik KS (2009) microRNA-124: micromanager of neurogenesis. Cell Stem Cell 4(5):375-376. doi:10.1016/j.stem.2009.04.007
77. Makeyev EV, Zhang J, Carrasco MA, Maniatis T (2007) The microRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 27(3):435-448. doi:10.1016/j.molcel.2007.07.015
78. Theuns J, Brouwers N, Engelborghs S, Sleegers K, Bogaerts V, Corsmit E, De Pooter T, van Duijn CM, De Deyn PP, Van Broeckhoven C (2006) Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet 78(6):936-946. doi:10.1086/504044
79. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, Campion D (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38(1):24-26. doi:10.1038/ng1718
80. Podlisny MB, Lee G, Selkoe DJ (1987) Gene dosage of the amyloid beta precursor protein in Alzheimer's disease. Science 238(4827):669-671
81. de Sauvage F, Kruys V, Marinx O, Huez G, Octave JN (1992) Alternative polyadenylation of the amyloid protein precursor mRNA regulates translation. EMBO J 11(8):3099-3103
82. Niwa R, Zhou F, Li C, Slack FJ (2008) The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans. Dev Biol 315(2):418-425. doi:10.1016/ j.ydbio.2007.12.044
83. Fan X, Liu Y, Jiang J, Ma Z, Wu H, Liu T, Liu M, Li X, Tang H (2010) miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai) 42(5):318-324
84. Patel N, Hoang D, Miller N, Ansaloni S, Huang Q, Rogers JT, Lee JC, Saunders AJ (2008) MicroRNAs can regulate human APP levels. Mol Neurodegener 3:10. doi:10.1186/1750-1326- 3-10
85. Long JM, Lahiri DK (2011) microRNA-101 downregulates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 404(4):889-895. doi:10.1016/j.bbrc.2010.12.053
86. Vilardo E, Barbato C, Ciotti M, Cogoni C, Ruberti F (2010) microRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem 285(24):18344-18351. doi:10.1074/jbc.M110.112664
87. Liu W, Liu C, Zhu J, Shu P, Yin B, Gong Y, Qiang B, Yuan J, Peng X (2012) microRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice. Neurobiol Aging 33(3):522-534. doi:10.1016/j. neurobiolaging.2010.04.034
88. Delay C, Calon F, Mathews P, Hebert SS (2011) Alzheimerspecific variants in the 30UTR of amyloid precursor protein affect microRNA function. Mol Neurodegener 6:70. doi: 10.1186/1750-1326-6-70
89. Liang C, Zhu H, Xu Y, Huang L, Ma C, Deng W, Liu Y, Qin C (2012) microRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Res 1455:103-113. doi:10.1016/j.brainres.2011.10.051
90. Broytman O, Westmark PR, Gurel Z, Malter JS (2009) Rck/p54 interacts with APP mRNA as part of a multi-protein complex and enhances APP mRNA and protein expression in neuronal cell lines. Neurobiol Aging 30(12):1962-1974. doi:10.1016/ j.neurobiolaging.2008.02.011
91. Rajagopalan LE, Malter JS (2000) Growth factor-mediated stabilization of amyloid precursor protein mRNA is mediated by a conserved 29-nucleotide sequence in the 30-untranslated region. J Neurochem 74(1):52-59
92. Zaidi SH, Malter JS (1995) Nucleolin and heterogeneous nuclear ribonucleoprotein C proteins specifically interact with the 30-untranslated region of amyloid protein precursor mRNA. J Biol Chem 270(29):17292-17298
93. Amara FM, Junaid A, Clough RR, Liang B (1999) TGF-beta(1), regulation of Alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization. Brain Res Mol Brain Res 71(1):42-49
94. Glinsky GV (2008) An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway. Cell Cycle 7(16):2570-2583
95. Laird FM, Cai H, Savonenko AV, Farah MH, He K, Melnikova T, Wen H, Chiang HC, Xu G, Koliatsos VE, Borchelt DR, Price DL, Lee HK, Wong PC (2005) BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci 25(50):11693-11709. doi:10.1523/ JNEUROSCI.2766-05.2005
96. Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, Beach T, Sue L, Wong P, Price D, Li R, Shen Y (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9(1):3-4. doi:10.1038/ nm0103-3
97. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, Finch CE, St Laurent G 3rd, Kenny PJ, Wahlestedt C (2008) Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 14(7):723-730. doi:10.1038/nm1784
98. Faghihi MA, Zhang M, Huang J, Modarresi F, Van der Brug MP, Nalls MA, Cookson MR, St-Laurent G 3rd, Wahlestedt C (2010) Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 11(5):R56. doi: 10.1186/gb-2010-11-5-r56
99. Zong Y, Wang H, Dong W, Quan X, Zhu H, Xu Y, Huang L, Ma C, Qin C (2011) miR-29c regulates BACE1 protein expression. Brain Res 1395:108-115. doi:10.1016/j.brainres.2011.04.035
100. Boissonneault V, Plante I, Rivest S, Provost P (2009) microRNA- 298 and microRNA-328 regulate expression of mouse betaamyloid precursor protein-converting enzyme 1. J Biol Chem 284(4):1971-1981. doi:10.1074/jbc. M807530200
101. Massone S, Vassallo I, Fiorino G, Castelnuovo M, Barbieri F, Borghi R, Tabaton M, Robello M, Gatta E, Russo C, Florio T, Dieci G, Cancedda R, Pagano A (2011) 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis 41(2):308-317. doi:10.1016/j.nbd.2010.09.019
102. Puglielli L, Ellis BC, Saunders AJ, Kovacs DM (2003) Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis. J Biol Chem 278(22):19777-19783. doi:10.1074/jbc. M300466200
103. Geekiyanage H, Chan C (2011) microRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J Neurosci 31(41): 14820-14830. doi:10.1523/JNEUROSCI.3883- 11.2011
104. Liu KP, Kuo MC, Tang KC, Chau AW, Ho IH, Kwok MP, Chan WC, Choi RH, Lam NC, Chu MM, Chu LW (2011) Effects of age, education and gender in the Consortium to Establish a Registry for the Alzheimer's Disease (CERAD)-Neuropsychological Assessment Battery for Cantonese-speaking Chinese elders. Int Psychogeriatr 23(10):1575-1581. doi:10.1017/ S1041610211001153
105. Hirsch-Reinshagen V, Burgess BL, Wellington CL (2009) Why lipids are important for Alzheimer disease? Mol Cell Biochem 326(1-2):121-129. doi:10.1007/s11010-008-0012-2
106. Kim J, Yoon H, Ramirez CM, Lee SM, Hoe HS, Fernandez- Hernando C (2012) miR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp Neurol 235(2):476-483. doi:10.1016/j.expneurol.2011.11.010
107. Akram A, Schmeidler J, Katsel P, Hof PR, Haroutunian V (2010) Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus. Brain Res 1318:167-177. doi:10.1016/j.brainres. 2010.01.006
108. Litman P, Barg J, Rindzoonski L, Ginzburg I (1993) Subcellular localization of tau mRNA in differentiating neuronal cell culture: implications for neuronal polarity. Neuron 10(4):627-638
109. Behar L, Marx R, Sadot E, Barg J, Ginzburg I (1995) cis-acting signals and trans-acting proteins are involved in tau mRNA targeting into neurites of differentiating neuronal cells. Int J Dev Neurosci 13(2):113-127
110. Larcher JC, Gasmi L, Viranaicken W, Edde B, Bernard R, Ginzburg I, Denoulet P (2004) Ilf3 and NF90 associate with the axonal targeting element of Tau mRNA. Faseb J 18(14): 1761-1763. doi:10.1096/fj.04-1763fje
111. Hebert SS, Papadopoulou AS, Smith P, Galas MC, Planel E, Silahtaroglu AN, Sergeant N, Buee L, De Strooper B (2010) Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet 19(20):3959-3969. doi:10.1093/hmg/ddq311
112. Smith PY, Delay C, Girard J, Papon MA, Planel E, Sergeant N, Buee L, Hebert SS (2011) microRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet 20(20):4016-4024. doi:10.1093/hmg/ddr330
113. Davis TH, Cuellar TL, Koch SM, Barker AJ, Harfe BD, McManus MT, Ullian EM (2008) Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J Neurosci 28(17):4322-4330. doi:10.1523/ JNEUROSCI.4815-07.2008
114. Kawase-Koga Y, Low R, Otaegi G, Pollock A, Deng H, Eisenhaber F, Maurer-Stroh S, Sun T (2010) RNAase-III enzyme Dicer maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells. J Cell Sci 123(Pt 4):586-594. doi:10.1242/jcs.059659
115. Bilen J, Liu N, Burnett BG, Pittman RN, Bonini NM (2006) microRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell 24(1):157-163. doi:10.1016/j.molcel. 2006.07.030
116. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3(4):519-526
117. D'Souza I, Schellenberg GD (2005) Regulation of tau isoform expression and dementia. Biochim Biophys Acta 1739(2-3): 104-115. doi:10.1016/j.bbadis. 2004.08.009
118. Caffrey TM, Joachim C, Paracchini S, Esiri MM, Wade-Martins R (2006) Haplotype-specific expression of exon 10 at the human MAPT locus. Hum Mol Genet 15(24):3529-3537. doi:10.1093/ hmg/ddl429
119. Liu F, Gong CX (2008) Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener 3:8. doi:10.1186/1750-1326-3-8
120. Ke Y, Dramiga J, Schutz U, Kril JJ, Ittner LM, Schroder H, Gotz J (2012) Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's Disease. PLoS ONE 7(4):e35678. doi:10.1371/journal.pone. 0035678
121. Wang J, Gao QS, Wang Y, Lafyatis R, Stamm S, Andreadis A (2004) Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors. J Neurochem 88(5):1078-1090
122. Tollervey JR, Wang Z, Hortobagyi T, Witten JT, Zarnack K, Kayikci M, Clark TA, Schweitzer AC, Rot G, Curk T, Zupan B, Rogelj B, Shaw CE, Ule J (2011) Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res 21(10):1572-1582. doi:10.1101/gr.122226.111
123. Sterne-Weiler T, Howard J, Mort M, Cooper DN, Sanford JR (2011) Loss of exon identity is a common mechanism of human inherited disease. Genome Res 21(10):1563-1571. doi:10.1101/ gr.118638.110
124. Cai Z, Zhao Y, Zhao B (2012) Roles of Glycogen synthase kinase 3 in Alzheimer's disease. Curr Alzheimer Res [Epub ahead of print]
125. Mohamed JS, Lopez MA, Boriek AM (2010) Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase- 3beta. J Biol Chem 285(38):29336-29347. doi:10.1074/jbc. M110.101147
126. Caputo V, Sinibaldi L, Fiorentino A, Parisi C, Catalanotto C, Pasini A, Cogoni C, Pizzuti A (2011) Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding. PLoS ONE 6(12):e28656. doi:10.1371/journal.pone.0028656
127. Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, McGowan E, Lewis J, Prihar G, Kim J, Dillmann WH, Browne SE, Hall A, Voellmy R, Tsuboi Y, Dawson TM, Wolozin B, Hardy J, Hutton M (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet 13(7):703-714. doi:10.1093/hmg/ddh083
128. Min SW, Cho SH, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, Huang EJ, Shen Y, Masliah E, Mukherjee C, Meyers D, Cole PA, Ott M, Gan L (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67(6):953- 966. doi:10.1016/j.neuron.2010.08.044
129. Gan L, Mucke L (2008) Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 58(1):10-14. doi:10.1016/ j.neuron.2008.03.015
130. Julien C, Tremblay C, Emond V, Lebbadi M, Salem N Jr, Bennett DA, Calon F (2009) Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 68(1):48-58. doi:10.1097/NEN.0b013e3181922348
131. Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, Yamanaka S, Willenbring H, Verdin E (2010) miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) 2(7):415-431
132. Schonrock N, Humphreys DT, Preiss T, Gotz J (2012) Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-beta. J Mol Neurosci 46(2):324-335. doi:10.1007/s12031-011-9587-2
133. Zovoilis A, Agbemenyah HY, Agis-Balboa RC, Stilling RM, Edbauer D, Rao P, Farinelli L, Delalle I, Schmitt A, Falkai P, Bahari-Javan S, Burkhardt S, Sananbenesi F, Fischer A (2011) microRNA-34c is a novel target to treat dementias. EMBO J 30(20):4299-4308. doi:10.1038/emboj.2011.327
134. Carrettiero DC, Hernandez I, Neveu P, Papagiannakopoulos T, Kosik KS (2009) The cochaperone BAG2 sweeps paired helical filament- insoluble tau from the microtubule. J Neurosci 29(7):2151-2161. doi:10.1523/JNEUROSCI.4660-08.2009
135. Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT (2011) Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 121(2):193-205. doi:10.1007/s00401-010-0756-0
136. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298(5594):789-791. doi:10.1126/science.1074069
137. Sutton MA, Schuman EM (2006) Dendritic protein synthesis, synaptic plasticity, and memory. Cell 127(1):49-58. doi: 10.1016/j.cell.2006.09.014
138. Siegel G, Saba R, Schratt G (2011) microRNAs in neurons: manifold regulatory roles at the synapse. Curr Opin Genet Dev 21(4):491-497. doi:10.1016/j.gde.2011.04.008
139. Mus E, Hof PR, Tiedge H (2007) Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci USA 104(25):10679-10684. doi:10.1073/pnas.0701532104
140. Minamide LS, Striegl AM, Boyle JA, Meberg PJ, Bamburg JR (2000) Neurodegenerative stimuli induce persistent ADF/cofilin- actin rods that disrupt distal neurite function. Nat Cell Biol 2(9):628-636. doi:10.1038/35023579
141. Whiteman IT, Gervasio OL, Cullen KM, Guillemin GJ, Jeong EV, Witting PK, Antao ST, Minamide LS, Bamburg JR, Goldsbury C (2009) Activated actin-depolymerizing factor/ cofilin sequesters phosphorylated microtubule-associated protein during the assembly of Alzheimer-like neuritic cytoskeletal striations. J Neurosci 29(41):12994-13005. doi:10.1523/ JNEUROSCI.3531-09.2009
142. Yao J, Hennessey T, Flynt A, Lai E, Beal MF, Lin MT (2010) microRNA-related cofilin abnormality in Alzheimer's disease. PLoS ONE 5(12):e15546. doi:10.1371/journal.pone.0015546
143. Li L (2004) Regulation of innate immunity signaling and its connection with human diseases. Curr Drug Targets Inflamm Allergy 3(1):81-86
144. Cui JG, Li YY, Zhao Y, Bhattacharjee S, Lukiw WJ (2010) Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J Biol Chem 285(50):38951-38960. doi:10.1074/jbc.M110.178848
145. The ENCODE Project Consortium (2011) A user's guide to the encyclopedia